![Eric MEULEMAN | Retired | M.D. PhD. | Amsterdam University Medical Center, Amsterdam | VUmc | Department of Urology | Research profile Eric MEULEMAN | Retired | M.D. PhD. | Amsterdam University Medical Center, Amsterdam | VUmc | Department of Urology | Research profile](https://i1.rgstatic.net/ii/profile.image/1179480504709126-1658221474890_Q512/Eric-Meuleman.jpg)
Eric MEULEMAN | Retired | M.D. PhD. | Amsterdam University Medical Center, Amsterdam | VUmc | Department of Urology | Research profile
![Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges | Molecular Pharmaceutics Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00523/asset/images/medium/mp2c00523_0003.gif)
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges | Molecular Pharmaceutics
![2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists | Journal of Medicinal Chemistry 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm100181s/asset/images/large/jm-2010-00181s_0001.jpeg)
2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists | Journal of Medicinal Chemistry
![Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges | Molecular Pharmaceutics Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00523/asset/images/large/mp2c00523_0001.jpeg)